6Harokopakis E, Hajishengallis G, Michalek SM. Effectiveness of liposomes possessing surface-linked recombinant B subunit of cholera toxin as an oral antigen delivery system[J]. Infect Immun, 1998, 66(9) :4299-4304.
7Iwanaga K, Ono S, Nerioka K, et al. Application of surfacecoated liposomes for oral delivery of peptide: effects of coating the liposome's surface on the GI transit of insulin[J] .J Pharm Sci, 1999, 88(2) :248-252.
8Takeuchi H, Matsui Y, Yamamoto H, et al. Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats [ J ]. J Control Release, 2003, 86 (2-3): 235 -242.
9Schwendener RA, Horber DH, Odermatt B, et al. Oral antitumour activity in murine L1210 leukaemia and pharmacological properties of liposome formulations of N4-alkyl derivatives of 1beta-D-arabinofuranosylcytosine[J]. J Cancer Res Clin Oncol,1996,122(2): 1
10Han M, Watarai S, Kobayashi K, et al. Application of liposome for development of oral vaccines:study of in vitro stability of liposomes and antibody response to antigen associated with liposomes after oral immunization [J]. J Vet Med Sci, 1997, 59(12):110
